Latest Development Programs News

Micro-X Limited lifted revenues by 16% to $15.1 million for FY26 but posted a $9.9 million net loss, narrowing from the prior year. The company advanced key medical imaging milestones and initiated a strategic reset to sharpen commercial focus and reduce costs.

Civmec delivered a robust FY26 with 11.4% revenue growth and a 22.5% jump in net profit, underpinned by a diversified project pipeline and strategic defence expansion.

Clinuvel Pharmaceuticals marked its tenth consecutive profit with stable revenues and rising cash reserves, while accelerating U.S. expansion including a Nasdaq uplisting and potential ASX delisting.

Argent BioPharma has secured a key FDA regulatory milestone with the establishment of an Investigational New Animal Drug (INAD) file for its CannEpil veterinary program, targeting cancer-related pain in companion animals.

Metallium has resolved a key permitting constraint at its Texas Gator Point campus, enabling chlorinated Flash Joule Heating testing to resume ahead of a major September campaign. The company also marks first revenue from its MXene development program and strengthens engineering leadership.

Veris Limited lifted revenue by 4.9% to $102 million in FY26, driven by digital and advisory growth, but statutory net profit fell 67% amid one-off costs and macroeconomic headwinds.

NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.

1414 Degrees has inked a letter of intent with South Korea’s JR Energy Solution to jointly develop and scale battery cells using its SiNTL silicon anode technology, targeting defence, UAV, space, and robotics markets.

Island Pharmaceuticals has commissioned a second manufacturing run of its antiviral Galidesivir, aiming to stockpile up to 800 treatment courses by late 2026 to support rapid response to the fast-spreading Bundibugyo Ebola outbreak and biodefence efforts.

Noumi Limited lifted FY26 revenue by 8.8% and adjusted operating EBITDA by 7.6%, driven by Dairy & Nutritionals' strong earnings and strategic investments in Plant-based Milks. The company faces refinancing uncertainty with $610 million convertible notes maturing in May 2027, prompting a proposed acquisition by majority shareholder Arrovest.

Native Mineral Resources is on track to surpass 1,000 ounces of gold production in a single month for the first time at its Blackjack operation, backed by a strong August smelting run and advancing multi-pit development.

Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.